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Phosphorylation of phospholamban in cardiac sarcolemma is implicated in the increased influx of Ca2+ 
through the slow calcium channel induced by catecholamines. A method is described for the preparation 
of highly purified sarcolemmal vesicles from rat heart, and this has been used to examine the 
phosphorylation of phospholamban i 32Pi-perfused rat hearts. Phospholamban phosphorylation is
increased 3-fold after 30 s of perfusion with 0.1 yM isoprenaline. The time course of this increase precedes 
the inotropic response by S-10 s. 
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1. INTRODUCTION 
Phospholamban is an intrinsic membrane pro- 
tein of cardiac muscle membranes which is 
phosphorylated by cyclic AMP-dependent [l] and 
Ca2+/calmodulin-dependent [2] protein kinases. It 
was originally reported to have an A4, of 23 000 [3], 
but has subsequently been dissociated into smaller 
subunits [4-81. It was first described in sar- 
coplasmic reticulum vesicles, where phosphoryla- 
tion caused a stimulation of Ca2+ uptake. It was 
suggested that phosphorylation of phospholamban 
was implicated in the enhancement of the rate of 
relaxation of the heart caused by ,&adrenoceptor 
agonists 191. More recently, phospholamban has 
been shown to be present in sarcolemma [lo]. 
Phosphorylation of sarcolemmal vesicles by en- 
dogenous protein kinases enhanced the activity of 
the sarcolemmal Ca2+ transport ATPase [11,12]. 
However, the significance of this in the regulation 
of Ca2+ fluxes in vivo is unclear, as the ATPase 
transports only a very small proportion of the total 
cytoplasmic Ca2+ during relaxation [ 131. Microin- 
jection of the catalytic subunit of cyclic AMP- 
dependent protein kinase (C-subunit) into single 
cardiac myocytes enhanced the slow inward 
calcium current during depolarisation [ 141. Patch- 
clamp experiments [15] have also shown that this 
current is increased by cyclic AMP. Enhancement 
of the calcium current is largely responsible for 
elongation of the action potential after exposure of 
hearts to &agonists [16]. Although in these ex- 
periments the target proteins for phosphorylation 
were not identified, it seems reasonable to propose 
that phosphorylation of phospholamban may be 
implicated in this response. 
We report that phosphorylation of phospholam- 
ban in sarcolemma is stimulated in intact hearts 
perfused with isoprenaline. This was measured in 
sarcolemmal vesicles prepared free of sarcoplasmic 
reticulum contamination. The time course of 
phosphorylation during isoprenaline perfusion was 
very rapid, and preceded the inotropic response. 
This supports the hypothesis that phosphorylation 
in the sarcolemma mediates the increase in the slow 
calcium current induced by catecholamines. 
Published by Elsevier Science Publishers B. V. 
00145793/83/$3.00  1983 Federation of European Biochemical Societies 297 
Volume 163, number 2 FEBS LETTERS November 1983 
2. MATERIALS AND METHODS 
2.1. Preparation and characterisation of 
sarcolemmal vesicles 
Sarcolemmal vesicles were prepared from frozen 
rat hearts by an adaptation of the method of [12]. 
Four hearts were powdered in the frozen state, 15 
ml of 0.75 M KCl, 0.2 mM dithiothreitol or 30 
mM 2-mercaptoethanol, 5 mM histidine (pH 7.4) 
(buffer A) at 0°C added to the powder, and 
homogenisation carried out for 1 s in a small- 
volume blender. All subsequent steps were per- 
formed at 0-4°C. The homogenate was degassed 
under vacuum and centrifuged at 3000 x g for 15 
min. The pellet was re-homogenised for 3 s in 15 
ml of buffer A and re-centrifuged. The pellet was 
stirred by hand with a glass rod for l-2 min with 
25 ml of 10 mM NaHC03, 0.2 mM dithiothreitol 
or 30 mM 2-mercaptoethanol, 5 mM histidine (pH 
7.4) (buffer B). Unhomogenised material was 
removed and the suspension re-centrifuged as 
above. The pellet was homogenised in 20 ml buffer 
l B using a Polytron (PTlO probe) at setting 6 with 
3 bursts of 25 s each. The homogenate was cen- 
trifuged at 8OOOxg for 20 min, and the superna- 
tant re-centrifuged at 36 000 x g for 45 min. The 
pellet was resuspended in 1 ml of 0.25 M sucrose, 
5 mM histidine (pH 7.2) and layered onto a 10 ml 
gradient of sucrose (0.52-1.02 M) containing 0.6 
M KCl, 10 mM histidine (pH 7.2). This was cen- 
trifuged in a swing-out rotor at 11OOOOxg for 60 
min. A tight, very pale band was formed just 
below the top of the gradient. This was removed, 
diluted with 8 vols of 0.6 M KCl, and centrifuged 
at 50 000 x g for 30 min. This pellet is referred to 
as the sarcolemmal vesicle preparation. A yield of 
10 pg protein per g heart was routinely obtained. 
(Na+ + K+)-ATPase, K+-stimulated p-nitrophe- 
nylphosphatase activity, and Ca’+-stimulated 
Mg’+-ATPase activity were measured in the 
presence of alamethicin as in [12]. ATP- 
dependent Ca2+ uptake was measured as in [12], 
using Tris-ATP to initiate uptake. Succinate 
dehydrogenase was assayed essentially as in [17], 
and 5 ’ -nucleotidase in the presence of Triton 
X-100 as in [18]; 
2.2. Perfusion and analysis of phosphorylated 
proteins 
Hearts were perfused with 32Pi (0.25 mCi per 
298 
heart) for 20-25 min as in [19], and then with 0.1 
PM DL-isoprenaline for various times up to 30 s 
when the hearts were freeze-clamped at - 186°C. 
Sarcolemmal vesicles were isolated as described 
above, but with the inclusion of 15 mM phosphate 
and 15 mM F- in all buffers except the final 0.6 M 
KC1 step. These were included to inhibit 
dephosphorylation of proteins during the isolation 
procedure. The vesicles were dissolved in sample 
buffer and subjected to polyacrylamide gel elec- 
trophoresis in the presence of sodium dodecyl 
sulphate (SDS-PAGE) as in [20]. The standard 
sampe buffer (unless indicated otherwise) contain- 
ed 10% SDS, 0.6 M sucrose, 125 mM Tris-Cl, 0.45 
M 2-mercaptoethanol (pH 6.8). Samples were 
heated at 100°C for 5 min immediately before elec- 
trophoresis unless otherwise stated. Autoradio- 
graphy of the dried gells was performed as in [21]. 
32P incorporation into proteins was determined by 
densitometry using a Joyce-Loebl Chromscan 3 
connected to a Hewlett-Packard desk-top com- 
puter . Peak areas were corrected for the 
[Y-~~P]ATP specific radioactivity of the hearts, 
measured as in [22]. 
For in vitro phosphorylation experiments, sar- 
colemmal vesicles were incubated with 0.175 mM 
[y-32P]ATP (spec. act. 0.6-l Bq - pmol-‘), 10 mM 
NaF, 30 mM Na phosphate, 1 mM MgClz, 0.5 mM 
EGTA, -t 0.6 mg/ml C-subunit for 2 min at 37°C. 
The reaction was stopped by addition of 
trichloroacetic acid (final concentration 0.6 M) 
and the protein pellet washed with 25 mM Na 
phosphate before being dissolved in SDS-PAGE 
sample buffer. 
2.3. Materials 
Radiochemicals were obtained from Amersham. 
Alamethicin was a gift of Professor L. Will- 
Shalab. All other reagents were Analar grade, or 
the purest grade obtainable. 
3. RESULTS 
3.1. Characterisation of the sarcolemmal vesicle 
preparation 
The specific activities &mol product form- 
ed . h-’ . mg protein-‘) of the following enzymes in 
the sarcolemmal vesicles were: (Na+ + K+)- 
ATPase, 38.1; K+-stimulated p-nitrophenylphos- 
phatase, 11.9; 5’-nucleotidase, 5.6. Succinate 
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dehydrogenase activity was undetectable. Because 
of the high level of Mg2+-dependent ATPase ac- 
tivity (210pmol. h-’ . mg-‘), it was not possible to 
measure accurately the Ca’+-stimulated Mg2+- 
ATPase activity. The values for the sarcolemmal 
marker enzymes were approximately 50% of those 
reported in preparations of sarcolemmal vesicles 
from pig heart using this method [12]. However, 
these values indicate a high degree of sarcolemmal 
purity when compared to other preparations 
[23-251. 
Fig. 1 shows the time course of ATP-dependent 
Ca2+ uptake into the sarcolemmal vesicles. A 
number of characteristics of this uptake indicate 
that it is all due to sarcolemma, and that there is 
no contamination by sarcoplasmic reticulum in 
this preparation. Thus there is nc stimulation of 
Ca2+ uptake by oxalate, and uptake is still taking 
place in the absence of oxalate after several 
minutes [26]. Ca2+ uptake was rapid and linear 
during the first 30 s. The accumulated Ca2+ could 
be released from the vesicles by the addition of 40 
mM Na+ but not by 40 mM K+ (fig.2), indicating 
the presence of a Na+/Ca2+ antiporter. The two 
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Fig. 1. The ATP-dependent uptake of calcium by sar- 
colemmal vesicles. Calcium uptake was measured by in- 
cubation of vesicles with 1 mM ATP, 75 PM 4SCaC12 as
in [12]. Separation of bound 45Ca was by Millipore 
filtration. The assays were performed in the presence (A) 
or absence (A) of 2.5 mM K oxalate. All points were cor- 
rected for passive calcium binding, which was 8.90 or 
7.67 nmol . mg protein-’ in the presence or absence of 
oxalate, respectively. Each point is the mean f SEM of 
3 determinations. 
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Fig. 2. The sodium-induced release of calcium from sar- 
colemmal vesicles. Vesicles were incubated with ATP 
and 45CaC12 asin fig. 1, and 45Ca uptake measured (0). 
After 5 min NaCl (+) or KC1 (A) were added to a final 
concentration of 40 mM. Error bars represent the SEM 
of 3 determinations. 
latter observations are characteristic of vesicles of 
sarcolemmal origin, whereas the first two results 
indicate no sarcoplasmic reticulum contamination. 
3.2. Characteristics of sarcolemmal 
phosphorylation 
Fig. 3a shows the autoradiograph scan of sar- 
colemmal vesicles phosphorylated in vitro by C- 
subunit. There are three major phosphorylated 
proteins of high mobility, with apparent M, values 
of 22000, 15000 and 11000. A minor 
phosphorylated protein of M, 6000, and several 
high-Mr proteins were also present. The four 
phosphorylated proteins of A&,<22 000 probably 
represent different states of aggregation of 
phospholamban subunits [7,25]. 
When sarcolemmal vesicles were prepared from 
hearts perfused with “Pi and stimulated for 30 s 
with isoprenaline, three proteins only were 
phosphorylated. These had h4, values of 15000, 
11000 and 6000 (fig.3b). If prior to electrophoresis 
the vesicles were dissolved in sample buffer con- 
taining 2% SDS and 5 mM MgC12 [8], there was 
generally only one phosphorylated protein with an 
Mr of 15000 (fig.3c), although occasionally a 
minor phosphorylated component with MI 6000 
was also seen. If either 10 mM MgC12 was present 
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Fig. 3. Densitometric traces of autoradiographs of 
phosphorylated sarcolemmal vesicles. Vesicle prepara- 
tions were dissolved in sample buffer as indicated, and 
subjected to SDS-PAGE with 15% polyacrylamide. (a) 
Vesicles were phosphorylated in vitro either with (-) 
or without (- - -) added C-subunit as described in sec- 
tion 2.2, and dissolved in sample buffer containing 10% 
SDS. (b and c) Vesicles were prepared from hearts per- 
fused with 32Pi, and dissolved in sample buffer contain- 
ing either 10% SDS (panel b) or 2% SDS, 5 mM MgCl2 
(panel c). (- - -) Control perfused hearts; (-) hearts 
perfused for 30 s with 0.1 PM isoprenaline. The arrows 
indicate the apparent MI values (+ 1000) of 
phospholamban subunits. PL indicates the position of 
phospholipid. 
in the sample buffer, or if the samples were 
dissolved in the absence of MgClz and then frozen 
before electrophoresis, the major phosphorylated 
protein had an M, of 22000 (not shown). 
Phospholamban has been shown to behave in an 
anomalous manner on SDS-PAGE. Thus heating 
and detergent [5-71 cause the protein to* migrate 
with A4, values of about 11000 and 6000, whereas 
Mg2+ [B] and freezing [7] give M, values of 22 000 
and 15000. The behaviour of the phosphorylated 
bands under various conditions in SDS-PAGE 
described above for sarcolemmal vesicles strongly 
suggests that all the bands represent different ag- 
gregation states of phospholamban. The absence 
of phosphorylated proteins of M, 19000 and 
27 000, which would correspond to myosin P-light 
chain [27] and troponin-I [19,27] respectively, in- 
dicate that this preparation is not contaminated by 
myofibrils. 
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Fig. 4. Time course of phosphorylation of sarcolemmal 
phospholamban in “Pi-perfused rat hearts in response 
to 0.1 FM isoprenaline (added at time = 0). (a) Vesicles 
were prepared from groups of 4 hearts frozen at the 
times indicated, and 32P incorporation into phospholam- 
ban measured by densitometry of autoradiographs of 
gels run under the conditions of fig.fc. Results are ex- 
pressed as % incorporation of 32P into phospholamban 
relative to that after 30 s of perfusion with isoprenaline. 
Each point is the mean f SEM of 4-7 groups of hearts. 
(b) Systolic peak tension, expressed relative to tension 
measured after 30 s of perfusion with isoprenaline. 
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The phosphorylation pattern obtained by in- 
cubation with C-subunit (fig.3a) clearly shows that 
several higher A4, proteins which can be 
phosphorylated in vitro are not phosphorylated in 
vivo. This may indicate denaturation of proteins 
during the vesicle preparation, exposing 
phosphorylation sites not available in vivo [28]. 
Alternatively, proteins not present on the 
cytoplasmic surface of the membranes will be 
available to the C-subunit if a proportion of the 
vesicles are prepared right-side-out. 
3.3. Time course of phospholamban 
phosphorylation in vivo 
Fig. 3 shows that the phosphorylation of 
phospholamban in sarcolemma is stimulated by 
perfusion of rat hearts with isoprenaline. The time 
course of this phosphorylation is shown in fig. 4 
along with the contractile response. Phospholam- 
ban phosphorylation preceded the increase in con- 
traction by 5-10 s. Thus phosphorylation was 
nearly maximal after 10 s of perfusion with 
isoprenaline, whereas maximal contractile force 
was only developed after 20-25 s. There was an ap- 
proximately 3-fold increase of phospholamban 
phosphorylation with isoprenaline perfusion. The 
basal phosphorylation level may be due to the ac- 
tivity of the Ca2+-dependent phospholamban 
kinase [12], rather than cyclic AMP-dependent 
protein kinase, since both troponin-I [19] and C- 
protein [27], two major substrates for the latter en- 
zyme, are only weakly phosphorylated in the 
absence of catecholamine. 
4. GENERAL DISCUSSION 
These experiments how that phospholamban is 
present in cardiac sarcolemma, and that its 
phosphorylation is increased by catecholamines. It
has been suggested [7] that phospholamban pre- 
sent in sarcolemmal vesicle preparations occurs 
either with the phosphorylation site on the ex- 
tracellular surface of the membrane, or in some 
contaminating membrane structures (not sar- 
coplasmic reticulum). Our results showing the 
phosphorylation of phospholamban in vivo make 
the first of these suggestions very unlikely. The se- 
cond suggestion cannot be disproved directly by 
our results, but a number of lines of evidence, 
discussed below, indicate a very close association 
between phosphorylation of phospholamban and 
changes in sarcolemmal calcium fluxes. 
It has been reported previously that sarcolemma 
contained a protein of M, 23 000, called calciductin 
[29], phosphorylation of which caused an apparent 
increase in the inward calcium current in a 
vesicular preparation. However, the calcium up- 
take measured in these experiments was probably 
not related to the inward current [30]. In addition, 
calciductin and phospholamban are probably iden- 
tical [31], and the preparation was probably con- 
taminated with sarcoplasmic reticulum [7]. 
Two earlier studies have also examined 
phosphorylation of proteins in sarcolemma in 
vivo. One of these 1321 reported the phosphoryla- 
tion of proteins of Mr 36000 and 27 000, but no 
protein corresponding to phospholamban. There 
was no evidence for phosphorylation of these 
higher M, proteins in our preparations in vivo, and 
we find it difficult to relate this study to the present 
results. The second study [33] showed an increase 
in phosphorylation of phospholamban with 
catecholamines in chick heart, but the sarcolemma 
preparations used were not free of other cell 
components. 
The studies involving microinjection of C-sub- 
unit [14], and the effects of cyclic AMP in patch- 
clamp experiments [ 151, both strongly suggest hat 
phosphorylation of a sarcolemmal protein is in- 
volved in the increased inward calcium current 
caused by catecholamines. Our experiments how 
that in vivo one protein only is phosphorylated in 
response to catecholamine, and that this protein 
appears to be identical with phospholamban. This 
is good evidence for the hypothesis that 
phosphorylation of phospholamban leads directly 
to an increased inward calcium current. The time 
course showing phosphorylation of phospholam- 
ban just preceding the increase in contraction also 
supports this argument. 
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